Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/GBE stock hub

FRA/GBE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/GBEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/GBEFRA/GBE

—

Loading chart…

In the news

Latest news · FRA/GBE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.7

P25 n/aP50 n/aP75 n/a

Trailing P/E33

P25 n/aP50 n/aP75 n/a

ROE9.4

P25 n/aP50 n/aP75 n/a

ROIC8.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/GBE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

GBP

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	3,190
Employees Change	-310%
Employees Change Percent	-8.86
Enterprise value	EUR 2B
Exchange	Frankfurt Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.8B
Price	EUR 27.8
Price currency	EUR
Rev Per Employee	241,477.36x
Sic	2836
Symbol	fra/GBE
Website	https://www.genusplc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.03%
EV Earnings	37.62x
EV/EBIT	17.87x
EV/EBITDA	13.99x
EV/FCF	35.11x
EV/Sales	2.63x
FCF yield	3.25%
Forward P/E	22.67x
P/B ratio	3.11x
P/E ratio	33.01x
P/S ratio	2.33x
PE Ratio10 Y	97.97x
PE Ratio3 Y	197.47x
PE Ratio5 Y	140.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.29%
EBITDA Margin	14.3%
FCF margin	7.57%
Gross margin	40.12%
Gross Profit	EUR 309M
Gross Profit Growth	-0.3%
Gross Profit Growth Q	-0.24%
Gross Profit Growth3 Y	1.83%
Gross Profit Growth5 Y	0.68%
Net Income	EUR 54.4M
Net Income Growth Q	1,762.5%
Net Income Growth3 Y	81.84%
Net Income Growth5 Y	7.36%
Pretax Margin	9.63%
Profit Margin	7.07%
Profit Per Employee	EUR 17,069
ROA	5.41
Roa5y	3.99
ROCE	10.5
ROE	9.35
Roe5y	5.25
ROIC	8.44
Roic5y	6.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.9%
Cagr1y	14.5%
Cagr3y	-1.17%
Cagr5y	-13.03%
Div CAGR10	3.03%
Div CAGR3	1.03%
Div CAGR5	2%
EPS Growth Q	1,754.2
EPS Growth3 Y	81.23
EPS Growth5 Y	7
FCF Growth	32.9%
FCF Growth Q	-14.29%
FCF Growth3 Y	50.27%
FCF Growth5 Y	15.75%
OCF Growth	30.63%
OCF Growth Q	-10.98%
OCF Growth10 Y	-1.1%
OCF Growth3 Y	29.29%
OCF Growth5 Y	5.02%
Revenue Growth	0.06x
Revenue Growth Q	-0.24x
Revenue Growth3 Y	0.16x
Revenue Growth5 Y	-0.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.7
Assets	EUR 1.1B
Cash	EUR 49.7M
Current Assets	EUR 351.3M
Current Liabilities	EUR 155.8M
Debt	EUR 298.8M
Debt EBITDA	EUR 2.37
Debt Equity	EUR 0.52
Debt FCF	EUR 5.12
Equity	EUR 577.6M
Interest Coverage	4.24
Liabilities	EUR 478.5M
Long Term Assets	EUR 704.8M
Long Term Liabilities	EUR 322.6M
Net Cash	EUR -249.1M
Net Cash By Market Cap	EUR -13.86
Net Debt EBITDA	EUR 2.26
Net Debt Equity	EUR 0.43
Net Debt FCF	EUR 4.27
Tangible Book Value	EUR 401.3M
Tangible Book Value Per Share	EUR 6.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.25
Inventory Turnover	5.16
Net Working Capital	EUR 160.8M
Quick ratio	1.25
Working Capital	EUR 193.8M
Working Capital Turnover	EUR 5.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.04%
Dividend Growth	-2.16%
Dividend Growth Years	0%
Dividend per share	EUR 0.38
Dividend Years	19
Dividend Yield	1.35%
Ex Div Date	2026-03-05
Last Dividend	EUR 0.13
Payout Frequency	Semi-Annual
Payout Ratio	44.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	61.32%
1Y total return	14.49%
200-day SMA	29.96
3Y total return	-3.47%
50-day SMA	29.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-50.25%
All Time High	71.5
All Time High Change	-61.12%
All Time High Date	2021-08-17
All Time Low	11.28
All Time Low Change	146.5%
All Time Low Date	2014-04-11
ATR	0.76
Ch YTD	-5.44
High	27.8
High52	36.4
High52 Date	2026-02-19
High52ch	-23.63%
Low	26.6
Low52	22.4
Low52 Date	2025-06-26
Low52ch	24.11%
Ma50ch	-6.71%
Price vs 200-day SMA	-7.21%
RSI	45.4
RSI Monthly	50.92
RSI Weekly	42.39
Sharpe ratio	0.47x
Sortino ratio	0.9
Total Return	-0.69%
Tr YTD	-5.05
Tr1m	-4.79%
Tr1w	2.96%
Tr3m	-19.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 94.7M
Operating Income Growth	20.94
Operating Income Growth Q	41.57
Operating Income Growth3 Y	15.29
Operating Income Growth5 Y	6.36
Operating margin	12.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65,889,510%
Net Borrowing	-25,548,197
Shares Insiders	0.34%
Shares Institutions	81.25%
Shares Qo Q	-0.31%
Shares Yo Y	2.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 48.6M
Average Volume	1.25x
Bv Per Share	8.74
CAPEX	EUR -15.5M
Ch10y	43.93
Ch1m	-4.79
Ch1w	2.96
Ch1y	13.01
Ch3m	-20.11
Ch3y	-7.7
Ch5y	-53.28
Ch6m	3.73
Change	1.46%
Change From Open	4.51
Close	27.4
Days Gap	-2.92
Depreciation Amortization	15,606,364.7
Dollar Volume	55.6
Earnings Date	2026-09-10
EBIT	EUR 94.7M
EBITDA	EUR 110.2M
EPS	EUR 0.81
F Score	5
FCF	EUR 58.3M
FCF EV Yield	2.85x
Financing CF	-56,054,011
Fiscal Year End	June
Founded	1,994
Goodwill	117,799,152.8
Graham Number	13.01258
Graham Upside	-53.19
Income Tax	EUR 19.5M
Investing CF	-13,984,845
Is Primary Listing	0
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Lynch Fair Value	EUR 6.2
Lynch Upside	-77.7
Ma150	30.23
Ma150ch	-8.03%
Ma20	28.61
Ma20ch	-2.83%
Net CF	5,502,234
Next Earnings Date	2026-09-10
Open	26.6
P FCF Ratio	30.8
P OCF Ratio	24.34
Payment Date	2026-03-27
Position In Range	100
Ppne	158,375,701.1
Price Date	2026-05-08
Price EBITDA	EUR 16.31
Ptbv Ratio	4.48
Relative Volume	1.6x
Revenue	770,312,786x
SBC By Revenue	1.26x
Share Based Comp	9,743,540
Tax By Revenue	2.53x
Tax Rate	26.28%
Tr6m	4.16%
Volume	2
Z Score	3.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/GBE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$0.38 annual per share

Payout ratio

+44.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.0%

0 consecutive years of growth

Total shareholder yield

-0.7%

Next ex-dividend date: 2026-03-05

Performance

FRA/GBE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/GBE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+81.2%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.0%

Negative means the company is buying back shares.

Technical

FRA/GBE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.4

Neutral momentum band

Price vs 200-day MA

-7.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/GBE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/GBE stock rating?

fra/GBE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/GBE analysis?

The full report lives at /stocks/fra/GBE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/GBE?

The latest report frames fra/GBE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/GBE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.